Minian Nadia, Baliunas Dolly, Zawertailo Laurie, Noormohamed Aliya, Giesbrecht Norman, Hendershot Christian S, Le Foll Bernard, Rehm Jürgen, Samokhvalov Andriy, Selby Peter L
Centre for Addiction and Mental Health, 100 Stokes Street, Toronto, ON, M6J1H4, Canada.
Implement Sci. 2017 May 18;12(1):65. doi: 10.1186/s13012-017-0595-7.
Tobacco and alcohol use present multiplicative risk for aerodigestive cancers. Reducing alcohol consumption improves smoking cessation outcomes and reduces cancer risk. Risky alcohol consumption and smoking are often treated separately despite concurrent treatment potentially leading to better outcomes for each. However, no rapidly scalable program exists for combined interventions in primary care clinics spread across wide geographic areas. This cluster randomized trial aims to report on the effects of a novel clinical decision support system (CDSS) on intervention rates by primary care practitioners addressing risky alcohol use in a smoking cessation program.
METHODS/DESIGN: We will be implementing a clinical decision support system (CDSS) in 221 primary care sites participating in the Smoking Treatment for Ontario Patients (STOP) program across Ontario, Canada. Sites will be blindly allocated to one of two clinical decision support systems guiding practitioners to provide a risky alcohol use intervention to smokers attempting to quit using nicotine replacement therapy (NRT). Risky alcohol use is defined as drinking above the Canadian Cancer Society's low-risk drinking guidelines. Primary analysis will measure the proportion of risky drinkers offered an alcohol intervention in each CDSS arm at baseline. Patients will be contacted by phone or email to track smoking cessation and alcohol consumption rates at 6- and 12-month follow-up.
Upon completion of the trial, the effect of different clinical decision support systems on practitioner behaviour, and on client tobacco and alcohol use, will be discussed. If the CDSS successfully promotes SBIRT for risky alcohol use in a primary care setting and/or improves patient-level outcomes, including smoking cessation rates and alcohol use reduction, this tool can be used as a model for other web-based behaviour change interventions integrated into primary care practice.
ClinicalTrials.gov NCT03108144.
烟草和酒精使用会增加上呼吸消化道癌症的发病风险。减少酒精摄入量可改善戒烟效果并降低癌症风险。尽管同时治疗可能会使每项治疗都取得更好的效果,但危险饮酒和吸烟问题往往分开处理。然而,对于分布在广泛地理区域的基层医疗诊所的联合干预措施,目前尚无快速可扩展的项目。这项整群随机试验旨在报告一种新型临床决策支持系统(CDSS)对基层医疗从业者在戒烟项目中针对危险饮酒进行干预的比率的影响。
方法/设计:我们将在加拿大安大略省参与安大略患者吸烟治疗(STOP)项目的221个基层医疗点实施临床决策支持系统(CDSS)。这些医疗点将被随机分配到两个临床决策支持系统之一,以指导从业者对尝试使用尼古丁替代疗法(NRT)戒烟的吸烟者进行危险饮酒干预。危险饮酒的定义为饮酒量超过加拿大癌症协会的低风险饮酒指南。主要分析将测量每个CDSS组在基线时接受酒精干预的危险饮酒者的比例。将通过电话或电子邮件联系患者,以跟踪6个月和12个月随访时的戒烟和酒精消费率。
试验完成后,将讨论不同临床决策支持系统对从业者行为以及对患者烟草和酒精使用的影响。如果CDSS能在基层医疗环境中成功促进针对危险饮酒的筛查、简短干预和转诊治疗(SBIRT),和/或改善患者层面的结果,包括戒烟率和酒精使用减少情况,那么这个工具可作为其他整合到基层医疗实践中的基于网络的行为改变干预措施的模型。
ClinicalTrials.gov NCT03108144。